RadioBDC Logo
Flaws | Bastille Listen Live
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Critics worry Stewart trial won't bring major change

Lawmakers scrutinize interaction of FDA, SEC

By Ross Kerber
Globe Staff / January 12, 2004
Text size +
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.

Will the Martha Stewart case lead to major changes in the way biotechnology companies are regulated? (Full article: 922 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass